BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1776267)

  • 1. Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
    Galtier P; Alvinerie M; Plusquellec Y; Tufenkji AE; Houin G
    Xenobiotica; 1991 Jul; 21(7):917-24. PubMed ID: 1776267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of experimental fascioliasis on the activity of drug-metabolizing enzymes in lamb liver.
    Galtier P; Larrieu G; Tufenkji AE; Franc M
    Drug Metab Dispos; 1986; 14(1):137-41. PubMed ID: 2868858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological basis for hepatic drug metabolism in sheep.
    Galtier P; Alvinerie M
    Vet Res; 1996; 27(4-5):363-72. PubMed ID: 8822607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy.
    Moreno L; Echevarria F; Muñoz F; Alvarez L; Sanchez Bruni S; Lanusse C
    Exp Parasitol; 2004; 106(3-4):150-7. PubMed ID: 15172222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The metabolism of albendazole in the isolated perfused intestine of rats].
    Lawrenz A; Eglit S; Kroker R
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):416-8. PubMed ID: 1425320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep.
    Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
    J Vet Pharmacol Ther; 2006 Jun; 29(3):213-23. PubMed ID: 16669866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver microsomal biotransformation of albendazole in deer, cattle, sheep and pig and some related wild breeds.
    Velík J; Baliharová V; Skálová L; Szotáková B; Wsól V; Lamka J
    J Vet Pharmacol Ther; 2005 Aug; 28(4):377-84. PubMed ID: 16050818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro oxidative metabolism of xenobiotics in the lancet fluke (Dicrocoelium dendriticum) and the effects of albendazole and albendazole sulphoxide ex vivo.
    Bártíková H; Vokřál I; Skálová L; Lamka J; Szotáková B
    Xenobiotica; 2010 Sep; 40(9):593-601. PubMed ID: 20560773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep.
    Galtier P; Coulet M; Sutra JF; Biro-Sauveur B; Alvinerie M
    Exp Parasitol; 1994 Sep; 79(2):166-76. PubMed ID: 7914496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sulphobromophthalein, lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep.
    Tufenkji AE; Alvinerie M; Houin G; Galtier P
    Res Vet Sci; 1987 Nov; 43(3):327-30. PubMed ID: 3444979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gender in the disposition of albendazole metabolites in humans.
    Mirfazaelian A; Dadashzadeh S; Rouini MR
    Eur J Clin Pharmacol; 2002 Sep; 58(6):403-8. PubMed ID: 12242599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of albendazole in sheep.
    Marriner SE; Bogan JA
    Am J Vet Res; 1980 Jul; 41(7):1126-9. PubMed ID: 7436109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole.
    Lanusse CE; Nare B; Prichard RK
    Xenobiotica; 1993 Mar; 23(3):285-95. PubMed ID: 8498091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of albendazole for prevention of fascioliasis in sheep.
    Rew RS; Knight RA
    J Am Vet Med Assoc; 1980 Jun; 176(12):1353-4. PubMed ID: 6107285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle.
    Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
    Drug Metab Dispos; 2004 May; 32(5):536-44. PubMed ID: 15100176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative incidence of experimental fascioliasis on corticosteroid pharmacokinetics in sheep.
    Alvinerie M; Tufenkji AE; Houin G; Toutain PL; Galtier P
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(1):81-6. PubMed ID: 2576748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of Fasciola hepatica infected sheep to various infection levels.
    Chauvin A; Moreau E; Boulard C
    Vet Res; 2001; 32(1):87-92. PubMed ID: 11254181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.